John Hancock Multifactor Healthcare ETF

JHMH tracks an index composed of US health care stocks, with heavier weighting toward smaller-cap, lower-relative-price and higher-profitability companies.

John Hancock Multifactor Media and Communications ETF

John Hancock Multifactor Materials ETF

John Hancock Multifactor Consumer Discretionary ETF

John Hancock Multifactor Energy ETF

JH Mltfct Fncls Shs

John Hancock Multifactor Industrials ETF

John Hancock Multifactor Consumer Staples ETF

John Hancock Multifactor Technology ETF

John Hancock Dynamic Municipal Bond ETF

BOSTON, Sept. 22, 2022 /PRNewswire/ - John Hancock Investment Management, a company of Manulife Investment Management, announced today that it plans to close and liquidate 10 sector ETFs (funds). The decision reflects how these funds have been used by investors over the past seven years and how sector investing has shifted in the market.

John Hancock Investment Management announces changes to its ETF lineup

VanEck Vectors Biotech ETF

Virtus LifeSci Biotech Products ETF

Principal Healthcare Innovators Index ETF

Loncar Cancer Immunotherapy ETF

Direxion Daily Healthcare Bull 3x Shares

First Trust NYSE Arca Biotechnology Index Fund

Fidelity MSCI Health Care ETF

First Trust Nasdaq Pharmaceuticals ETF 

First Trust Health Care AlphaDEX Fund

Amplify Treatments Testing & Advancements ETF

Global X Genomics & Biotechnology ETF

abrdn Healthcare Investors 

abrdn Life Sciences Investors 

iShares Nasdaq Biotechnology ETF

Defiance Nasdaq Junior Biotechnology ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare ETF

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

Global X Longevity Thematic ETF

Invesco Dynamic Biotechnology & Genome ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

ProShares UltraShort Health Care

ProShares Ultra Health Care

Invesco S&P 500 Equal Weight Health Care ETF

Vanguard Health Care ETF

Pacer BioThreat ETF

SPDR S&P Biotech ETF

Health Care Select Sector SPDR Fund

SPDR S&P Pharmaceuticals ETF

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.

Biotech Innovations Remain At Forefront

AbbVie

LeMaitre Vascular

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets.

Healthcare: A Wide Choice Of Large And Well-Established Companies

John Hancock Multifactor Large Cap ETF

John Hancock Multifactor Mid Cap ETF

John Hancock Multifactor Small Cap ETF

While 2020 may feel like a “this time it's different” year, the reality is the core underpinnings of what makes for a winning portfolio haven't changed: controlling expenses, managing your taxes, and most importantly, having the right exposures for the current market regime. But with wild swings in both sectors and factors, how do you [.

Cracking Open Factors: Beyond the Style Box

As more take a harder look at their portfolio composition, many investors are turning to smart beta exchange traded funds to enhance their portfolios and meet the challenges ahead. “They’re kind of really starting to re-evaluate portfolios, and that’s kind of where our multi-factor ETFs come in as they’re used to using the cheap beta, [.

Smart Beta ETFs to Better Engage with Current Markets

News for John Hancock Multifactor Healthcare ETF ETF (JHMH)